Specialized Medical Company (TADAWUL:4019)
18.39
+0.08 (0.44%)
Apr 29, 2026, 3:19 PM AST
TADAWUL:4019 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 | Upgrade
|
| Depreciation & Amortization | 93.05 | 87.48 | 87.76 | 103.94 | 102.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | -60.49 | 2.29 | 0.02 | -0.06 | -0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.39 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 12.64 | 9.68 | 6.21 | 36.13 | 51.32 | Upgrade
|
| Other Operating Activities | 56.49 | 48.05 | 56.65 | 34.69 | 23.28 | Upgrade
|
| Change in Accounts Receivable | -65.37 | 92.16 | -89.05 | -121.1 | -111.96 | Upgrade
|
| Change in Inventory | -4.4 | 3.19 | -5.89 | -0.79 | 4.56 | Upgrade
|
| Change in Accounts Payable | 11.01 | -10.99 | 4.68 | 14.87 | -32.13 | Upgrade
|
| Change in Other Net Operating Assets | 13.19 | -33.3 | 4.3 | 6.85 | -178.17 | Upgrade
|
| Operating Cash Flow | 322.74 | 383.78 | 233.37 | 177.48 | -84.25 | Upgrade
|
| Operating Cash Flow Growth | -15.91% | 64.45% | 31.49% | - | - | Upgrade
|
| Capital Expenditures | -94.46 | -94.27 | -72.84 | -60.89 | -75.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.93 | 0.84 | 0.06 | 0.2 | Upgrade
|
| Investment in Securities | -3.13 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -97.56 | -93.34 | -72 | -60.82 | -74.94 | Upgrade
|
| Short-Term Debt Issued | 658.28 | 760.54 | 20 | 15 | 170 | Upgrade
|
| Long-Term Debt Issued | 200 | - | - | - | 47.71 | Upgrade
|
| Total Debt Issued | 858.28 | 760.54 | 20 | 15 | 217.71 | Upgrade
|
| Short-Term Debt Repaid | -902.29 | -685 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -94.52 | -85.51 | -53.44 | -46.96 | -25.84 | Upgrade
|
| Total Debt Repaid | -996.81 | -770.51 | -53.44 | -46.96 | -25.84 | Upgrade
|
| Net Debt Issued (Repaid) | -138.53 | -9.98 | -33.44 | -31.96 | 191.88 | Upgrade
|
| Common Dividends Paid | - | -200 | -60 | -50 | -35 | Upgrade
|
| Other Financing Activities | 67.57 | -35.81 | -41.88 | -25.73 | -16.34 | Upgrade
|
| Financing Cash Flow | -70.97 | -245.78 | -135.33 | -107.69 | 140.54 | Upgrade
|
| Net Cash Flow | 154.21 | 44.66 | 26.04 | 8.97 | -18.65 | Upgrade
|
| Free Cash Flow | 228.28 | 289.52 | 160.53 | 116.6 | -159.38 | Upgrade
|
| Free Cash Flow Growth | -21.15% | 80.35% | 37.68% | - | - | Upgrade
|
| Free Cash Flow Margin | 14.84% | 20.14% | 11.73% | 9.65% | -15.13% | Upgrade
|
| Free Cash Flow Per Share | 0.91 | 1.16 | 1.89 | 1.37 | -1.88 | Upgrade
|
| Cash Interest Paid | 32.43 | 35.81 | 41.88 | 25.73 | 16.34 | Upgrade
|
| Levered Free Cash Flow | 87.69 | 172.75 | 41.2 | 251.67 | -201.45 | Upgrade
|
| Unlevered Free Cash Flow | 114.24 | 200.98 | 71.48 | 270.31 | -189.65 | Upgrade
|
| Change in Working Capital | -45.57 | 51.06 | -85.97 | -100.17 | -317.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.